ZEPP
Zepp Health Corporation
3.80$
-3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.6% | +245.6% | +2.2% | +0.8% | +45.5% | -35.4% | +52.6% | +26.3% | +10.9% | -40.5% | +21.9% | – | |
| – | -0.6% | +234.7% | -3.4% | +0.2% | +54.7% | -35.8% | +55.2% | +22.4% | +5.8% | -38.2% | +22.9% | – | |
| – | +3.1% | +266.0% | +11.9% | +1.7% | +31.9% | -34.6% | +48.1% | +33.3% | +19.0% | -43.9% | +20.2% | – | |
| – | +8.8% | +766.1% | -19.0% | -3.2% | +5.7% | +11.7% | -10.8% | -4.1% | +0.3% | +0.0% | +2.2% | – | |
| – | -21.4% | +784.7% | -89.4% | +44.8% | +181.9% | -67.1% | +388.2% | +56.5% | -45.2% | -12.1% | +2.1% | – | |
| – | +6.6% | +679.0% | -13.9% | +9.5% | +7.5% | +5.9% | -16.6% | +7.0% | +28.3% | -4.6% | -4.0% | – | |
| – | -57.8% | -18,140.7% | – | – | – | – | – | – | – | – | – | – | |
| – | -10.1% | +620.4% | -4.4% | -9.4% | +16.5% | -6.3% | -9.3% | +17.7% | +7.7% | +0.6% | +0.4% | – | |
| – | +238.7% | -7,098.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +4,165.0% | -81.4% | -34.4% | +36.2% | +21,129.9% | -99.2% | +117.8% | -52.1% | +1,643.6% | -89.8% | -47.3% | – | |
| – | -413.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -49.1% | -8,663.0% | – | – | – | – | – | – | -894.1% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.